98 related articles for article (PubMed ID: 3830774)
1. [In vitro, activity of a new macrolide (RU 28965) against Chlamydia trachomatis and Ureaplasma urealyticum].
Sambri V; Rumpianesi F; Franchi L; Cevenini R
G Ital Chemioter; 1985; 32(1):175-6. PubMed ID: 3830774
[No Abstract] [Full Text] [Related]
2. In vitro activity of ciprofloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
Rumpianesi F; Sambri V; Bertini S; Tamba I; Cevenini R
Chemioterapia; 1984 Jun; 3(3):173-4. PubMed ID: 6529772
[TBL] [Abstract][Full Text] [Related]
3. [Comparative in vitro activity of a new macrolide RU 28965 and of erythromycin against Chlamydia trachomatis].
Dutilh B; de Barbeyrac B; Lafferrière C; Bébéar C
Pathol Biol (Paris); 1986 May; 34(5):445-7. PubMed ID: 3534718
[TBL] [Abstract][Full Text] [Related]
4. The activity of miokamycin (MOM) against Chlamydia trachomatis and mycoplasmas in vitro.
Ridgway GL; Mumtaz G; Gabriel G; Oriel JD
J Antimicrob Chemother; 1983 Nov; 12(5):511-4. PubMed ID: 6608516
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activity of RU 28965 against Chlamydia trachomatis.
Cevenini R; Sambri V; La Placa M
Eur J Clin Microbiol; 1986 Oct; 5(5):598-600. PubMed ID: 3536506
[No Abstract] [Full Text] [Related]
6. In vitro antimicrobial activity of rosoxacin against Neisseria gonorrhoeae, Chlamydia trachomatis, and Ureaplasma urealyticum.
Dobson RA; O'Connor JR; Poulin SA; Kundsin RB; Smith TF; Came PE
Antimicrob Agents Chemother; 1980 Nov; 18(5):738-40. PubMed ID: 6778385
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of amifloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
Freeman S; Wormuth J; Cornett J
Eur J Clin Microbiol; 1985 Oct; 4(5):515-6. PubMed ID: 4065142
[No Abstract] [Full Text] [Related]
8. Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis.
Bébéar CM; de Barbeyrac B; Pereyre S; Renaudin H; Clerc M; Bébéar C
Clin Microbiol Infect; 2008 Aug; 14(8):801-5. PubMed ID: 18727805
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of antibiotics against Ureaplasma urealyticum and Chlamydia trachomatis strains from patients with nongonococcal urethritis.
Busolo F; Conventi L
Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):407-10. PubMed ID: 3137045
[TBL] [Abstract][Full Text] [Related]
10. Rosamicin, a macrolide with in vitro activity against Ureaplasma urealyticum.
Hill AC; Sutton G
J Antibiot (Tokyo); 1979 Sep; 32(9):915-9. PubMed ID: 511782
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis.
Kilic D; Basar MM; Kaygusuz S; Yilmaz E; Basar H; Batislam E
Jpn J Infect Dis; 2004 Feb; 57(1):17-20. PubMed ID: 14985631
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis.
Bowie WR; Shaw CE; Chan DG; Black WA
Antimicrob Agents Chemother; 1987 Mar; 31(3):470-2. PubMed ID: 2953304
[TBL] [Abstract][Full Text] [Related]
13. The activity of ciprofloxacin and other 4-quinolones against Chlamydia trachomatis and Mycoplasmas in vitro.
Ridgway GL; Mumtaz G; Gabriel FG; Oriel JD
Eur J Clin Microbiol; 1984 Aug; 3(4):344-6. PubMed ID: 6237903
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity of U-70138F (paldimycin), roxithromycin (RU 965), and ofloxacin (ORF 18489) against Chlamydia trachomatis in cell culture.
Stamm WE; Suchland R
Antimicrob Agents Chemother; 1986 Nov; 30(5):806-7. PubMed ID: 3467650
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility of Ureaplasma urealyticum to rosaramicin.
Smith TF
Antimicrob Agents Chemother; 1979 Jul; 16(1):106-8. PubMed ID: 475368
[TBL] [Abstract][Full Text] [Related]
16. [Antimicrobial sensitivity of Ureaplasma urealyticum in vitro].
Martinez MA; Pinto ME
Rev Med Chil; 1985 Mar; 113(3):220-4. PubMed ID: 2940655
[No Abstract] [Full Text] [Related]
17. Activities of new quinoline derivatives against genital pathogens.
Aznar J; Caballero MC; Lozano MC; de Miguel C; Palomares JC; Perea EJ
Antimicrob Agents Chemother; 1985 Jan; 27(1):76-8. PubMed ID: 3920959
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial activity of bitespiramycin, a new genetically engineered macrolide.
He W; Yang C; Zhao X; Wang Y
Bioorg Med Chem Lett; 2017 Oct; 27(19):4576-4577. PubMed ID: 28867456
[TBL] [Abstract][Full Text] [Related]
19. Anti-mycoplasmal activity of a new macrolide: miocamycin.
Furneri PM; Tempera G; Bisignano G; Cottarelli FV; Nicoletti G
Chemioterapia; 1987 Oct; 6(5):341-5. PubMed ID: 3501335
[TBL] [Abstract][Full Text] [Related]
20. [Methods of studying the sensitivity of Chlamydia trachomatis to antibiotics].
Laurans G; Orfila J; Haider F
Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique; 1982; (2-3):93-106. PubMed ID: 7187965
[No Abstract] [Full Text] [Related]
[Next] [New Search]
